Bibliographic Details
| Title: |
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer. |
| Authors: |
Rustin, G.1, Vergote, I.2, Micha, J.P.3, Duska, L.R.4, Reed, N.5, Bendell, J.6, Spitz, D.7, Dark, G.8, Hoch, U.9, Tagliaferri, M.9, Hannah, A.L.9, Garcia, A.A.10,11 agarc6@lsuhsc.edu |
| Source: |
Gynecologic Oncology. Nov2017, Vol. 147 Issue 2, p276-282. 7p. |
| Database: |
Academic Search Ultimate |
